drugset / Trial / NCT00849511

Melatonin for Migraine Prevention

NCT00849511

Phase 2 Completed 48 enrolled Nordland Hospital University of Tromso · collab
RandomizedCrossoverDouble-blindPrevention

Summary

The circadian system with its centre in the hypothalamus is involved in migraine pathophysiology. Whether it plays a pivotal role is not clarified. The investigators postulate that a destabilized circadian system may increase migraine attack susceptibility, and that stabilization by supplying melatonin a migraine preventive effect will be achieved. A previous open label study has shown effects that certainly warrant a placebo controlled study.

Timeline

Start
2009-02
Primary completion
2009-09
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Melatonin Small molecule 2 mg

Indications